While this is not a side effect in the traditional sense, it's important to be aware that long-term use of high doses for skin-lightening purposes may have unintended consequences and may not be safe
For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients
Available in Box, Push set, and Drip Set good for 10 sessions
We do not guarantee the accuracy of the content in the reference
Wai KM, et al
These molecules support intestinal integrity and influence metabolic signaling pathways involved in insulin sensitivity and appetite control